Alerts will be sent to your verified email
Verify Email
WANBURY
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Wanbury Limited is a prominent Indian pharmaceutical company ranked among the top 50 in the country. Specializing in API sales globally and domestic formulations, Wanbury has a significant presence in the industry.
Wanbury major competitors are Bharat Parenterals, Anuh Pharma, Kwality Pharma, Ind-Swift Lab., Lincoln Pharma, Sakar Healthcare, Shivalik Rasayan.
Market Cap of Wanbury is ₹910 Crs.
While the median market cap of its peers are ₹875 Crs.
Wanbury seems to be less financially stable compared to its competitors.
Altman Z score of Wanbury is 3.76 and is ranked 6 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Jun | Mar Jun Sep Dec | Dec | |||||||||||||||
| Investor Presentation | ||||||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
